The abstract is read at the publisher; the summary is JClub's.
Accelerated repetitive transcranial magnetic stimulation (arTMS) shows moderate antidepressant benefit versus sham (Hedges' g = 0.61; 95% CI 0.38 to 0.85) across 44 randomized trials (N = 1671).
- Why it matters: The field lacks clear evidence on whether arTMS works differently across symptom domains and how stimulation dose and participant factors shape neuroplastic, transdiagnostic responses.
- What they did: A preregistered systematic review and random-effects meta-analysis (PROSPERO: CRD42024536096) pooled 44 sham-controlled RCTs and used meta-regressions to test stimulation parameters and demographics as moderators.
- The result: arTMS also improved anxiety (g = 0.43), obsessive-compulsive symptoms (g = 0.45), working memory (g = 0.45), and declarative memory (g = 0.30), with mild, transient adverse events and domain-specific moderation by frequency, interval, dose, age, and sex.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.